Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety, tolerability, pharmacokinetics, and antitumor activity of adavosertib in Japanese patients with advanced solid tumors: A phase I, open-label study.
Kondo S, Katsuya Y, Yonemori K, Komuro K, Sugeno M, Kawata T, Ghiorghiu D, Meulendijks D, Yamamoto N. Kondo S, et al. Among authors: sugeno m. Cancer Treat Res Commun. 2024;39:100809. doi: 10.1016/j.ctarc.2024.100809. Epub 2024 Mar 24. Cancer Treat Res Commun. 2024. PMID: 38593512 Free article. Clinical Trial.
Maternal septic shock due to Acinetobacter lwoffii infection:a case report.
Isogami H, Sugeno M, Imaizumi K, Fukuda T, Kamo N, Yasuda S, Yamaguchi A, Fujimori K. Isogami H, et al. Among authors: sugeno m. Fukushima J Med Sci. 2023 Nov 15;69(3):191-196. doi: 10.5387/fms.2022-43. Epub 2023 Sep 28. Fukushima J Med Sci. 2023. PMID: 37766560 Free PMC article.
Peritoneal and Ovarian Tuberculosis with Massive Ascites.
Nakamura K, Sugeno M, Watahiki Y, Kanemitsu K. Nakamura K, et al. Among authors: sugeno m. Intern Med. 2024 Feb 1;63(3):469-470. doi: 10.2169/internalmedicine.2013-23. Epub 2023 Jun 21. Intern Med. 2024. PMID: 37344427 Free PMC article. No abstract available.
Safety/tolerability, efficacy and pharmacokinetics of 600-μg cotadutide in Japanese type 2 diabetes patients with a body mass index of 25 kg/m2 or higher: A phase I, randomized, double-blind, placebo-controlled study.
Asano M, Sekikawa A, Sugeno M, Matsuoka O, Robertson D, Hansen L. Asano M, et al. Among authors: sugeno m. Diabetes Obes Metab. 2023 Aug;25(8):2290-2299. doi: 10.1111/dom.15107. Epub 2023 Jun 19. Diabetes Obes Metab. 2023. PMID: 37337366 Clinical Trial.
23 results